© 2003 by European Society of Cardiology
Copyright © 2003, European Society of Cardiology
Overexpression of calcineurin in mouse causes sudden cardiac death associated with decreased density of K+ channels
Cardiovascular Research Group, Department of Medicine, University of Calgary, 3330 Hospital Drive N.W., Calgary, Alberta, Canada T2N 4N1
* Corresponding author. Tel.: +1-403-220-6841; fax: +1-403-270-0313. hduff{at}ucalgary.ca
Background: Overexpression of calcineurin in transgenic (TG) mice results in cardiac hypertrophy and unexpected deaths. Methods and results: None of the TG survived beyond 24 weeks (n=38) whereas all of the wildtype (WT, n=47) survived. Prolongation of repolarization preceded the development of sustained pleomorphic ventricular tachycardia and high degree atrioventricular block, which occurred during spontaneous sudden deaths. Since depolarization-activated K+ channels contribute dominantly to repolarization in mice, we hypothesized that the TG would decrease these K+ currents and that the in vivo administration of cyclosporin A (CsA), a calcineurin inhibitor, would reduce this effect. CsA reversed cardiac hypertrophy: capacitance measurements of WT left ventricular myocytes (127±7 pF; n=45) and CsA-treated TG (129±14 pF; n=17) were significantly lower than in placebo-treated TG (220±11 pF; n=41; P<0.001 by ANOVA). Independent of whether the data fit a bi- or a tri-exponential model, the density of Itof was significantly reduced in TG versus WT and CsA reversed this effect. While Itos and IKslow were also reduced in TG, CsA does not reverse this change because long-term in vivo CsA treatment of WT also reduces Itos and IKslow. To assess whether the decreased repolarization reserve contributed to arrhythmogenesis, the residual IKr was blocked by dofetilide precipitating pleomorphic ventricular tachycardias. Conclusion: Since the downregulation of Itof was observed with overexpression of calcineurin and was also reversed by the calcineurin inhibitor CsA, we conclude that downregulation of Itof is a consequence of calcineurin overexpression.
KEYWORDS Tau1, relates to the IKslow component; Tau2, relates to the Itos component; Tau3, relates to the Itof component; TG, transgene; TGCsA, transgene treated with CsA; WT, wildtype; WTCsA, wildtype treated with CsA
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. Kinoshita, K. Kuwahara, M. Takano, Y. Arai, Y. Kuwabara, S. Yasuno, Y. Nakagawa, M. Nakanishi, M. Harada, M. Fujiwara, et al. T-Type Ca2+ Channel Blockade Prevents Sudden Death in Mice With Heart Failure Circulation, September 1, 2009; 120(9): 743 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. MacDonnell, J. Weisser-Thomas, H. Kubo, M. Hanscome, Q. Liu, N. Jaleel, R. Berretta, X. Chen, J. H. Brown, A.-K. Sabri, et al. CaMKII Negatively Regulates Calcineurin-NFAT Signaling in Cardiac Myocytes Circ. Res., August 14, 2009; 105(4): 316 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Michael, L. Xiao, X.-Y. Qi, D. Dobrev, and S. Nattel Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis Cardiovasc Res, February 15, 2009; 81(3): 491 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Y. Qi, Y.-H. Yeh, L. Xiao, B. Burstein, A. Maguy, D. Chartier, L. R. Villeneuve, B. J.J.M. Brundel, D. Dobrev, and S. Nattel Cellular Signaling Underlying Atrial Tachycardia Remodeling of L-type Calcium Current Circ. Res., October 10, 2008; 103(8): 845 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Somers, P. L. Beck, J. P. Lees-Miller, D. Roach, Y. Li, J. Guo, S. Loken, S. Zhan, L. Semeniuk, and H. J. Duff iNOS in cardiac myocytes plays a critical role in death in a murine model of hypertrophy induced by calcineurin Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1122 - H1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Marionneau, S. Brunet, T. P. Flagg, T. K. Pilgram, S. Demolombe, and J. M. Nerbonne Distinct Cellular and Molecular Mechanisms Underlie Functional Remodeling of Repolarizing K+ Currents With Left Ventricular Hypertrophy Circ. Res., June 6, 2008; 102(11): 1406 - 1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Abriel Roles and regulation of the cardiac sodium channel Nav1.5: Recent insights from experimental studies Cardiovasc Res, December 1, 2007; 76(3): 381 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Bondarenko and R. L. Rasmusson Simulations of propagated mouse ventricular action potentials: effects of molecular heterogeneity Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1816 - H1832. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Anderson Multiple downstream proarrhythmic targets for calmodulin kinase II: Moving beyond an ion channel-centric focus Cardiovasc Res, March 1, 2007; 73(4): 657 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gong, I. Bodi, C. Zobel, A. Schwartz, J. D. Molkentin, and P. H. Backx Calcineurin Increases Cardiac Transient Outward K+ Currents via Transcriptional Up-regulation of Kv4.2 Channel Subunits J. Biol. Chem., December 15, 2006; 281(50): 38498 - 38506. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guo, S. Zhan, J. Somers, R. E. Westenbroek, W. A. Catterall, D. E. Roach, R. S. Sheldon, J. P. Lees-Miller, P. Li, Y. Shimoni, et al. Decrease in density of INa is in the common final pathway to heart block in murine hearts overexpressing calcineurin Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2669 - H2679. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S.C. Khoo, J. Li, M. V. Singh, Y. Yang, P. Kannankeril, Y. Wu, C. E. Grueter, X. Guan, C. V. Oddis, R. Zhang, et al. Death, Cardiac Dysfunction, and Arrhythmias Are Increased by Calmodulin Kinase II in Calcineurin Cardiomyopathy Circulation, September 26, 2006; 114(13): 1352 - 1359. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rubio, I. Bodi, G. A. Fuller-Bicer, H. S. Hahn, M. Periasamy, and A. Schwartz Sarcoplasmic Reticulum Adenosine Triphosphatase Overexpression in the L-type Ca2+ Channel Mouse Results in Cardiomyopathy and Ca2+-Induced Arrhythmogenesis Journal of Cardiovascular Pharmacology and Therapeutics, October 1, 2005; 10(4): 235 - 249. [Abstract] [PDF] |
||||
![]() |
H.-P. Vosberg The ubiquitin-proteasome system may be involved in the pathogenesis of hypertrophic cardiomyopathy Cardiovasc Res, April 1, 2005; 66(1): 1 - 3. [Full Text] [PDF] |
||||
![]() |
C.-C. Lin, J.-L. Lin, C.-S. Lin, M.-C. Tsai, M.-J. Su, L.-P. Lai, and S. K. S. Huang Activation of the Calcineurin-Nuclear Factor of Activated T-Cell Signal Transduction Pathway in Atrial Fibrillation Chest, December 1, 2004; 126(6): 1926 - 1932. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Gillis, K. M. Kavanagh, H. J. Mathison, J. R. Somers, S. Zhan, and H. J. Duff Heart block in mice overexpressing calcineurin but not NF-AT3 Cardiovasc Res, December 1, 2004; 64(3): 488 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. A. Janssen, T. De Celle, J. J. M. Debets, A. E. Brouns, M. F. Callahan, and T. L. Smith Effects of anesthetics on systemic hemodynamics in mice Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1618 - H1624. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Perrier, R. Perrier, S. Richard, and J.-P. Benitah Ca2+ Controls Functional Expression of the Cardiac K+ Transient Outward Current via the Calcineurin Pathway J. Biol. Chem., September 24, 2004; 279(39): 40634 - 40639. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dobrev Transcription factors for ion channels: active or passive players in cardiac remodeling? Cardiovasc Res, November 1, 2003; 60(2): 226 - 227. [Full Text] [PDF] |
||||
![]() |
R. B. Vega, R. Bassel-Duby, and E. N. Olson Control of Cardiac Growth and Function by Calcineurin Signaling J. Biol. Chem., September 26, 2003; 278(39): 36981 - 36984. [Full Text] [PDF] |
||||
![]() |
J. Li, A. Yatani, S.-J. Kim, G. Takagi, K. Irie, Q. Zhang, V. Karoor, C. Hong, G. Yang, J. Sadoshima, et al. Neurally-mediated increase in calcineurin activity regulates cardiac contractile function in absence of hypertrophy Cardiovasc Res, September 1, 2003; 59(3): 649 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wolk Calcineurin, myocardial hypertrophy, and electrical remodeling Cardiovasc Res, February 1, 2003; 57(2): 289 - 293. [Full Text] [PDF] |
||||






